Ranbaxy

Ranbaxy to restart production of generic version of cholesterol-lowering drug Lipitor

25 Feb 2013

Ranbaxy recalls generic Lipitor in US market over glass particles in bottles

24 Nov 2012

Ranbaxy to invest $40 million to set up a second plant in Malaysia

13 Sep 2012

Ranbaxy in licensing pact with Gilead for HIV drug

03 Aug 2012

Daiichi Sankyo to market Ranbaxy drugs in Venezuela

20 Jun 2012

Ranbaxy rides a generic sales boom to a Rs1,247-crore Q4 net profit

09 May 2012

Ranbaxy launches India's first new drug for malaria, Synriam

25 Apr 2012

Ranbaxy begins US exports of generic Lipitor from Mohali

02 Apr 2012

Ranbaxy opens new manufacturing facility in Morocco

12 Mar 2012

Ranbaxy launches cholesterol-lowering drug `Atorvastatin’ in Europe

06 Mar 2012

Ranbaxy may hand over Latin American marketing to Daiichi Sankyo

25 Feb 2012

Ranbaxy reports Rs2,983 crore Q4 loss on US probe provisioning

23 Feb 2012

Even  though its consolidated sales rose over 79 per cent over the last quarter of 2010, Ranbaxy Laboratories Ltd, has reported a net loss of Rs2,982.8 crore, mainly on provisioning related to a probe by the US justice department

Ranbaxy launches generic version of cholesterol-lowering drug Lipitor in Australia

21 Feb 2012

Ranbaxy today said it has become the first generic drug maker to sell the generic version of Pfizer's block-buster cholesterol-lowering drug Lipitor in Australia

Ranbaxy to pay $500 million to settle USFDA ban

21 Dec 2011

Ranbaxy to share Lipitor profits with Teva

02 Dec 2011

Teva today acknowledged that it has entered into a profit-sharing deal with Ranbaxy, but did not provide details of what it was doing to earn that money

US FDA lifts curbs on Ranbaxy's generic Lipitor sales

01 Dec 2011

The US FDA has lifted its curbs on sales of Ranbaxy Laboratories' generic version of Pfizer's blockbuster cholesterol drug Lipitor, whose patent expired yesterday

No immediate gain for Ranbaxy despite Lipitor patent's expiry

30 Nov 2011

Pfizer, Ranbaxy sued over Lipitor price fixing in the US

10 Nov 2011

Pfizer and Ranbaxy  have been sued for holding back a generic version of Pfizer’s cholesterol-lowering drug Lipitor in the US and then fixing its price.

Ranbaxy Labs reports Rs465-crore net loss for July-September quarter

09 Nov 2011

Ranbaxy to launch generic ‘Lipitor’ in US by November

09 Sep 2011

Ranbaxy Laboratories, India’s largest drugmaker, will launch a generic version of Lipitor, the world’s top-selling cholesterol control drug, in the US by November

Ranbaxy’s subsidiary launches esomeprazole in UK

05 Sep 2011

Ranbaxy introduces two-in-one painkiller 'Volini Duo' for OTC sales

12 Aug 2011

Ranbaxy April-June net down over 25 per cent at Rs243 crore

05 Aug 2011

Ranbaxy in settlement talks with USFDA: Reports

05 May 2011

Mylan Inc sues USFDA to block Ranbaxy’s Lipitor bid

21 Mar 2011